Technological Innovations in the Healthcare Industry Set to Propel Polysaccharide Hemostatic System Sales: Fact.MR Concludes in a Latest Market Study

170 Pages Market Research Survey by Fact MR, A Market Research and Competitive Intelligence Provider Highlights Key Trends Driving Polysaccharide Hemostatic System Market Growth

The Fact.MR market survey on the polysaccharide hemostatic systems market provides insights into recent developments across various segments in the market products, applications, and end-users. It also highlights growth strategies adopted by vendors to improve sales in the market

Fact.MR: Patients who undergo invasive medical procedures are often susceptible to excessive blood loss, especially cesarian deliveries and major organ surgeries. This has highlighted the pressing need for effective blood control management systems.

Owing to this factor, Fact.MR projects positive growth prospects for polysaccharide hemostatic system market during the forecast period 2021-2031.

Due to growing public awareness regarding minimally invasive medical procedures and pervasiveness of chronic diseases, the demand for polysaccharide hemostatic systems will increase at a positive pace.

These systems effectively control blood loss during surgeries involving sensitive and non-anatomical structures. Patients with hemostatic abnormalities have also been benefitting from these systems, which in turn is boosting applications of polysaccharide hemostatic systems.

Besides this, increasing adoption of polysaccharide hemostatic systems among healthcare providers can be attributable to reduction in surgery expenses and quick recovery post-surgical procedures.

In addition, growing frequency of surgical procedures in the geriatric population due to high bone density and arthritic disorders is underscoring the use of polysaccharide hemostatic systems in orthopedic surgeries.

As per Fact.MR’s market survey, the US polysaccharide hemostatic system market is anticipated to exhibit positive growth. Rapid adoption of advanced medical technology in healthcare and increasing per capita expenditure in the country are chief growth drivers of the market.

“Increasing cases of surgical procedures will create demand for effective polysaccharide hemostatic systems in the upcoming years. Product innovations and technological advancements in the same are anticipated to keep the market afloat,” says a Fact.MR analyst.

Request a report sample to gain comprehensive insights at

Key Takeaways from Polysaccharide Hemostatic System Market Survey

  • Sales outlook for polysaccharide hemostatic system market to positive for the period between 2021 and 2031.
  • In terms of applications, orthopedic surgeries will dominate the segment, followed by cardiovascular surgeries.
  • The U.S. polysaccharide hemostatic system market is anticipated to witness healthy growth through 2031, owing to wide adoption of technologically advanced medical systems.
  • The U.K. polysaccharide hemostatic system market will grow at a steady pace, owing to research and development and new product launches in the country.

Growth Drivers:

  • Research and development aimed at increasing product efficacy will lead to better sales prospects in polysaccharide hemostatic system market.
  •  Increasing adoption of technologically advanced medical devices will foster market sales in the upcoming years.

Request for customization at

Competitive Landscape

Leading players in the polysaccharide hemostatic system market are investing in research and development to enhance their product portfolio. Additionally, gaining patents and approvals from regulatory bodies will remain a major growth strategy for the market players. For instance, in February 2021, EndoClot Plus Inc., received the approval from U.S. Food and drug Administration (FDA) for its polysaccharide hemostatic system. The PHS system is a starch-based powder hemostat that reliably controls gastrointestinal bleeding.

Key Manufacturers of Polysaccharide Hemostatic System Include:

  • Starch Medical Inc.
  • Medical Expo
  • Medical Devices Business Services Inc.
  • CryoLife Inc.
  • EndoClot Plus Inc.

More Valuable Insights on Polysaccharide Hemostatic System Market

Fact MR provides an unbiased analysis of the polysaccharide hemostatic system market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global polysaccharide hemostatic system market with a detailed segmentation on the basis of:


  • Polysaccharide Hemostatic System


  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Gynecological surgery
  • Reconstructive surgery
  • Cardiovascular surgery


  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Community healthcare
  • Surgery Centers
  • Nursing Homes


  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Key Questions Covered in the Polysaccharide Hemostatic System Market Report 

  • The report offers insight into polysaccharide hemostatic system market demand outlook for 2021-2031
  • The market study also highlights projected sales growth for polysaccharide hemostatic system market between 2021 and 2031
  • Polysaccharide hemostatic system market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry 
  • Polysaccharide hemostatic system market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others  


Explore Fact.MR’s Coverage on the Healthcare Domain -

Arthritis Therapeutics Market- For companies in the arthritis therapeutics market, the rapid introduction of biologics brings new commercial prospects. Given the influence of favorable reimbursement scenarios that cushion the high cost, biologic medicine uptake is strong, particularly in developed countries of North America, Europe, and Asia Pacific. As a result of the high success rate of arthritis therapeutics, manufacturers are investing large sums to research and development, ensuring the continued availability of blockbuster pharmaceuticals.

Orthopedic Repair Market- Over the projected period, the rising prevalence and recurrence of diverticular disease is expected to be a prominent driver driving the orthopedic repair market. Several factors are expected to have an impact on the orthopedic repair industry. The orthopedic repair market is projected to be driven by patient-specific surgeries and implants. In the orthopedic repair sector, many instruments have been created to increase precision, as well as personalizing surgical cutting blocks to a patient's anatomy. Various orthopedic repair surgeries, such as spinal, maxillofacial, and prosthetic devices, will drive the orthopedic repair market.

Minimally Invasive Surgery Market- The demand for minimally invasive surgeries has risen dramatically in recent years, as people have become more interested in sophisticated surgical treatments with less side effects than traditional ones. Medical technology improvements have resulted in significant revenue increase for suppliers of minimally invasive surgery equipment in recent years. The need for diverse minimally invasive surgical equipment is developing tremendously as important end users such as ambulatory surgery centers, clinics, and hospitals continue to expand.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner. 


Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Back to news